International Summit on Psychedelic Therapies for Mental Illness (Mind Medicine Australia)

Mind Medicine Australia will hold a two-day International Summit on Psychedelic Therapies for Mental Illness in November 2021, bringing together clinicians, scientists, academics, mental and public health professionals, philanthropists, Government, law and policy leaders, business, industry, consumers and other interested stakeholders.

The event will also feature a two-day pre-Summit introductory workshop program (17-18 November) for anyone with an interest in the topic and who is considering further development of their current therapeutic skills or who are eager to gain a detailed understanding of psychedelic-assisted psychotherapy for the treatment of mental illness.

The Summit will feature a rich program with a mixture of international and national keynotes, workshops, hot spots and panel conversations.

Key themes will include:

• The current state of mental health in Australia, existing treatments and the need for innovation
  
• The Science of Psychedelics: Therapeutic mechanisms and clinical outcomes for a range of mental illnesses and other conditions
  
• Indigenous Wisdom and expanded states of consciousness for healing and growth
  
• Depression, Trauma, Addiction and Suicide: Prevention is better than cure
  
• Living until you die: the promise of psilocybin-assisted therapy for end-of-life
  
• The way forwards for Australia: Ethical, legal, and implementation frameworks for psychedelic treatments and a new paradigm for treatment of mental illness
  
• Creating the Future: What the Psychedelic Industry Will Look Like 5 Years Out?

Leading international speakers confirmed for the 2-day summit and Mind Medicine Australia Ambassadors include: Professor David Nutt (UK) Head of Neuropsychopharmacology at Imperial College London and Chief Research Officer at Awakn Life Sciences, Dr Gabor Maté (Canada) renowned trauma and addiction physician, Professor Roland Griffiths (USA) Professor in the Departments of Psychiatry and Neurosciences at the Johns Hopkins University School of Medicine, Dr Bill Richards (USA) world-leading therapist trainer and psychologist at the Johns Hopkins School of Medicine, Dr Ben Sessa (UK) Chief Medical Officer at Awakn Life Sciences, Psychiatrist, Researcher and Writer, Professor Robin Carhart-Harris (UK) Ralph Metzner Distinguished Professor, Weill Institute for Neurosciences and University of California San Francisco, Johann Hari (UK) Journalist and Bestselling Author, Francoise Bourzat (USA) Psychedelic Guide Trainer and Author, Wade Davis (Canada) anthropologist, ethnobotanist and Explorer in Residence at the National Geographic Society, Dr Alberto Villoldo (USA) medical anthropologist and author, Dr Lynn Marie Morski (USA) President of the Psychedelic Medicine Association, Professor Matthew Johnson (USA) Professor of Psychiatry and Behavioural Sciences at Johns Hopkins University School of Medicine with a focus on psychedelic research for the treatment of mental illness, Dr Reid Robinson (USA) psychedelic psychiatrist, Dr Jennifer Mitchell (USA) Professor in the Departments of Neurology and Psychiatry and Behavioral Sciences at UCSF, Patrycja Slawuta (USA) Researcher & Psychologist, Admiral Chris Barrie AC (AUS) former Head of the Australian Defence Force and Strategic Leadership Consultant, Professor Arthur Christopoulos (AUS) Professor of Analytical Pharmacology and Molecular Neuropsychopharmacologist at Monash University, Ronan Levy (Canada) Co-founder and the Executive Chairman of Field Trip Health, Srinivas Rao (USA) co-founder & Chief Scientific Officer, atai Life Sciences, Kelsey Ramsden (Canada) Co-Founder, CEO & President of Mindcure, Dr Lyle Oberg (Canada) Co-Founder and CEO at MYND, Michael Winlo (AUS) Managing Director, Emyria, Joseph Araujo (Canada) Co-Founder and Chief Scientific Officer of Mindset Pharma and the CEO and President of InterVivo Solutions, John Skerritt (AUS) Deputy Secretary, Health Products Regulation Group - TGA, Dr Simon Longstaff (AUS) Executive Director of The Ethics Centre, Dr Eli Kotler (AUS) Psychiatrist and Director of Medicine at Malvern Private Hospital… and more to be announced.

All delegates will receive the recordings of all key sessions and the presentations from keynote talks.

Mind Medicine Australia Summit
2 day Introductory Therapist Workshop Outline

Click here to view the full workshop program.

Main Summit event

Click here to view the full summit program.

Psychedelic therapies have been granted Breakthrough Therapy status by the FDA in the USA due to current promising research in the treatment of depression and PTSD. We look forward to collaborating with you to explore psychedelic treatment options to help address the mental health crisis we currently face, and offer treatments to those who need it most.

Together we can change the paradigm for mental health.

NOTE: This Introductory Workshop is open to doctors, therapists, patients and other interested members of the public.

Watch this video to find out how and understand why Mind Medicine Australia is committed to bringing about this opportunity for those who need it the most;

Learn more about Mind Medicine Australia at our website:
www.mindmedicineaustralia.com.au 

Learn more about the Summit at our website:
www.summit.mindmedicineaustralia.org

FAQs:
Is my ticket transferred over automatically to the virtual event?

Yes it is, we’ll take care of everything from here. There is nothing else required from your end.

What is happening to the 2-day pre-summit workshop?

This will also be held virtually. We have had experience with this format through our certification program and it will absolutely deliver a powerful educational experience.

I know someone can’t afford to attend the Summit but would love to learn more about Psychedelic-assisted therapies for mental illness, are there any free materials you can offer?

Absolutely, here’s a list:

Free upcoming online events: https://mindmedicineaustralia.org.au/events/

YouTube Channel with 48 videos: https://www.youtube.com/c/MindMedicineAustralia

Drug Education Slides: https://mindmedicineaustralia.org.au/educational-slides/

Podcast: https://mindmedicineaustralia.org.au/podcast/

Website: mindmedicineaustralia.org.au

Are there discounts for students, seniors, disability and concession card holders?

Yes! Please email us to enquire about this at: events@mindmedicineaustralia.org

 TERMS AND CONDITIONS

• All prices are inclusive of GST.
• Humanitix booking fees are added onto the ticket price. Booking fees include 30% donation to Mind Medicine Australia.
• Cancellation policy: Once booked, tickets are non-refundable. They are transferable.
• Invoices: You will receive an invoice from Humanitix directly.
• Group Bookings: Should you wish to book 3 or more delegates and receive an invoice or send a Purchase Order, please contact events@mindmedicineaustralia.org or call 03 8679 6000
• Early bookings are recommended to avoid disappointment.
• Privacy notice: Mind Medicine Australia is concerned with the protection of your privacy. We support the privacy principles contained in the Privacy Act 1988 (Cth), as amended. Mind Medicine Australia collects and stores your personal information for the purposes of providing membership services, education and training programs. Here is how your data may be used: Communication from Mind Medicine Australia: We may use your details to promote products and services in the form of email communications and/or other types of communication. Email events@mindmedicineaustralia.org if you would prefer not to receive communications from Mind Medicine Australia. For the purposes of the event: Your details will be provided to parties directly related to the conference including the conference registration manager, venues and accommodation providers for the purpose of room bookings, catering needs and other conference options. 
  
• Program: Mind Medicine Australia reserves the right to change the program at any time. Every effort will be made to ensure a program of equivalent standard.

Disclaimer

Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms (for example facebook, instagram and zoom private and public chat forms during the webinar). Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters.

Mind Medicine Australia is focused specifically on the clinical application of medicinal psilocybin and medicinal MDMA for certain mental illnesses.